Related Experiment Video
Updated: Mar 19, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?
1Molecular Medicine Unit, Clinical Sciences Building, St. James's University Hospital, University of Leeds, Leeds LS9 7TF, UK. m.a.hull@leeds.ac.uk
Abstract:
There is now substantial evidence for a role for cyclooxygenase-2 (COX-2)-mediated prostaglandin (PG) signalling during carcinogenesis in a number of tissues and selective COX-2 inhibitors (coxibs) were considered attractive candidate chemoprevention agents. However, recent concerns over the toxicity of systemic selective COX-2 inhibition and the realisation that COX-1 may also contribute to carcinogenesis have cast some doubt on COX-2 inhibition as a safe and effective chemoprevention strategy. This review will describe the available evidence relating to the known benefits (preventive efficacy in rodent tumorigenesis models and limited human data from small randomised, controlled trials and epidemiological studies) and risks (cardiovascular and renal toxicity) of coxib therapy for cancer chemoprevention. Potential, alternative strategies for inhibition of COX-PG signalling that minimise or avoid systemic selective COX-2 inhibition will also be discussed.
Insights
Selective COX-2 inhibitors show promise for cancer chemoprevention, but concerns about toxicity and COX-1
Area of Science:
- Oncology
- Pharmacology
Background:
- Cyclooxygenase-2 (COX-2) prostaglandin signaling is implicated in carcinogenesis.
- Selective COX-2 inhibitors (coxibs) were explored for cancer chemoprevention.
- Concerns about coxib toxicity and COX-1's role in cancer have emerged.
Purpose of the Study:
- To review the benefits and risks of coxib therapy for cancer chemoprevention.
- To discuss alternative strategies for inhibiting COX-prostaglandin signaling.
Main Methods:
- Review of existing evidence on coxib efficacy and toxicity.
- Analysis of rodent tumorigenesis models, human trials, and epidemiological studies.
- Exploration of alternative COX-PG signaling inhibition strategies.
Main Results:
- Coxibs demonstrate preventive efficacy in rodent models.
- Limited human data from small trials and epidemiological studies exist.
- Significant cardiovascular and renal toxicity risks are associated with coxibs.
Conclusions:
- COX-2 inhibition presents a complex chemoprevention strategy due to efficacy and toxicity.
- Alternative approaches to COX-PG signaling inhibition are needed to mitigate risks.
- Further research is required to balance benefits and risks for safe chemoprevention.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Cancer Prevention
Some...
Cancer Prevention
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

